MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaMicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade.MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.MicroRNAs in apoptosis, autophagy and necroptosisAberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.Conserved miR-26b enhances ovarian granulosa cell apoptosis through HAS2-HA-CD44-Caspase-3 pathway by targeting HAS2.Mechanisms of doxorubicin resistance in hepatocellular carcinomaMiR-153 promotes breast cancer cell apoptosis by targeting HECTD3TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cellsMicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancerRole of microRNAs in inflammation-associated liver cancerProof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection.Non-Coding RNAs in Primary Liver Cancer.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.Impact of miR-26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non-canonical Wnt signalling.Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway.miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells.Respiratory syncytial virus infection inhibits TLR4 signaling via up-regulation of miR-26b.MicroRNA-26b functions as a proapoptotic factor in porcine follicular Granulosa cells by targeting Sma-and Mad-related protein 4.Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction.TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex.Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
P2860
Q26743361-F28505DE-3F32-4A9B-B868-BB01E36169BAQ28079138-C629855A-CA39-4D4C-A365-3F7E2F8F11E4Q33775464-3813878E-1C59-4099-BB08-5A974EBD5218Q35176207-2FE704E7-9E53-4BA3-A3B5-8B88439F79F0Q35450947-04A28C80-5455-4F27-B200-1ABA016CC610Q35557213-01BAE99D-4080-436F-B3BC-AD134FC3ABCCQ35678702-B04F9BDB-EA40-470F-9D53-F26AD77E4766Q35752063-D672640A-1164-4432-9B82-BF03A769A6EBQ35755282-70DCEB38-B97B-45B8-8631-ECA5E7BBFC0FQ35832148-589EC8B9-02AB-4601-82F1-059678D738D1Q35854256-96536FF9-AB03-46DC-BC27-769901CE4B97Q36155971-88436C2A-2DDE-4D43-BBA3-4E1DE92F144BQ36212765-3C93FCC0-8BE3-4886-B82F-A96B714B1130Q36414297-6A98C410-7DEC-4AFF-8A7C-75D69B7AD048Q36414381-25D9527C-F523-4BD6-87C7-3403EF660241Q36508613-1AB71CE1-34A3-4389-BBE9-51F69ABC2163Q36592055-5CB86B0D-A5DB-4B15-B1D3-65CE95865896Q36687760-CCD92542-9658-4C04-88C5-71A8AC73FBFAQ37143959-F97059A1-05CA-40CD-803D-F60BD300C1A8Q37236747-F89BACE2-720A-49F6-92B5-41BB5F0488FCQ37457579-0012CEA1-FC43-429C-87A8-8FC988B9A618Q37596666-BE4CE63D-DC8F-4418-BCD0-081714428189Q37741183-1A825DDC-DCE1-4735-BCD0-977BFCBFABACQ38541359-1D60044A-09D7-454F-A289-B71B37846548Q38546133-A016B9BA-988B-47E0-8550-634207C264F3Q38568853-1B0ED497-EAEC-41DF-8468-3AA527A1884EQ38694883-283B318D-35ED-4ACF-9D60-D12183A76F02Q38733904-A339388D-5E68-4923-93C1-193AD579FC7BQ38740875-A9A8BE90-715C-4FF8-A13F-B9CF12D5AC2FQ38885288-45B0EF99-C7FF-48DA-A084-E10E5B5F64F7Q38901007-2EEDF0C7-A804-43AA-969A-C169EC24CB7BQ38937821-CAA88A22-1223-4D3A-8A4C-EFD5B3BA4FC7Q39986591-E7460F32-F260-4E1D-8A3A-4AFFA22BDABDQ40174969-5F360F4F-8AB6-4961-A1BF-B8C89766D3DAQ41084273-920915F8-EED2-4666-B1AD-814314095310Q44784192-B6C3127A-F3F1-447F-866C-BDE4B6AF50EBQ46489500-13CEAC40-4CB2-4C75-AFFD-F2166BDE2F80Q47094149-A6A6365E-E3D8-4C3F-9FD0-13B4FCB7A50BQ47612265-2CA3DCB5-A31D-43D7-80F0-5624DB3E411DQ47867288-F80C1067-DB79-4B4A-A6A4-723EE4B8A133
P2860
MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-26b suppresses the NF ...... ls by targeting TAK1 and TAB3.
@en
MicroRNA-26b suppresses the NF ...... ls by targeting TAK1 and TAB3.
@nl
type
label
MicroRNA-26b suppresses the NF ...... ls by targeting TAK1 and TAB3.
@en
MicroRNA-26b suppresses the NF ...... ls by targeting TAK1 and TAB3.
@nl
prefLabel
MicroRNA-26b suppresses the NF ...... ls by targeting TAK1 and TAB3.
@en
MicroRNA-26b suppresses the NF ...... ls by targeting TAK1 and TAB3.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-26b suppresses the NF ...... lls by targeting TAK1 and TAB3
@en
P2093
P2860
P2888
P356
10.1186/1476-4598-13-35
P577
2014-02-24T00:00:00Z
P5875
P6179
1001221401